Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jingfang Keli for cough variant asthma
ChiCTR2400083289Phase 4Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Jingfang Granules in cough variant asthma (CVA), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoint: Cough symptom score. Started Apr 2024; status: recruiting.
02
Drugs
Jingfang Granules
03
Conditions
cough variant asthma (CVA)
Beyond the preview
Go deeper on ChiCTR2400083289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083289.